128.28CHF-0.67%Mkt Cap: 284.58B $P/E: 22.793d ago
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Avg
P/B
Pricier
1M Perf
Lower
Indicators:|
Key Statistics
Company
Market Cap284.58B $
Enterprise Value322.60B $
Revenue (TTM)64.57B $
Gross Profit49.05B $
Net Income (TTM)15.96B $
Revenue/Share33.56 USD
Last Price128.28 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.3K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)22.79
P/E (Forward)—
PEG—
EV/EBITDA12.33
EV/Revenue5.00
P/S4.36
P/B7.89
EPS (TTM)5.63
EPS (Forward)—
52W Range
108.8495% of range129.40
52W High129.40 CHF
52W Low108.84 CHF
Profitability
Gross Margin75.83%
Oper. Margin30.48%
EBITDA Margin40.51%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth-0.70%
Earnings Growth-9.30%
Cash Flow & Leverage
Operating CF21.85B $
CapEx (TTM)4.45B $
FCF Margin21.25%
FCF Yield4.82%
Net Debt45.77B $
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.77
Current Ratio0.85
Quick Ratio0.53
Book Value/Sh16.09 CHF
Cash/Share3.612 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate4.666 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.0
Float1.81B
Insiders—
Institutions—
Technical
SMA 50118.05 (+8.7%)
SMA 200118.64 (+8.1%)
Beta0.49
S&P 52W Chg20.05%
Avg Vol (30d)130.25K
Avg Vol (10d)130.00K
Technical Indicators
RSI (14)66.9
MACD2.5762
MACD Signal1.9778
MACD Hist.+0.5984
BB Upper130.06 CHF
BB Middle122.82 CHF
BB Lower115.59 CHF
BB Width11.78%
ATR (14)2.302 CHF
Vol Ratio (20d)1.00x